1Gottesman, II, Shields, J. A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A 1967; 58: 199–205.
2Cardno, AG, Gottesman, II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12–7.
3The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–52.
4Sullivan, PF, Daly, MJ, O'Donovan, M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537–51.
5Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–7.
6Whalley, HC, Adams, MJ, Hall, LS, Clarke, TK, Fernandez-Pujals, AM, Gibson, J, et al. Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts. Transl. Psychiatry 2016; 6: e938.
7Hubbard, L, Tansey, KE, Rai, D, Jones, P, Ripke, S, Chambert, KD, et al. Evidence of common genetic overlap between schizophrenia and cognition. Schizophr Bull 2016; 42: 832–42.
8Riglin, L, Collishaw, S, Richards, A, Thapar, AK, Maughan, B, O'Donovan, MC, et al. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study. Lancet Psychiatry 2017; 4: 57–62.
9Boyd, A, Golding, J, Macleod, J, Lawlor, DA, Fraser, A, Henderson, J, et al. Cohort Profile: the ‘children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 2013; 42: 111–27.
10Fraser, A, Macdonald-Wallis, C, Tilling, K, Boyd, A, Golding, J, Davey Smith, G, et al. Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 2013; 42: 97–110.
11Jones, HJ, Stergiakouli, E, Tansey, KE, Hubbard, L, Heron, J, Cannon, M, et al. Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiat 2016; 73: 221–8.
12Buckley, PF, Miller, BJ, Lehrer, DS, Castle, DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009; 35: 383–402.
13Fergusson, DM, Horwood, LJ. The christchurch health and development study. In The Christchurch Experience: 40 Years of Research and Teaching (eds Joyce, P, Nicholls, G, Thomas, K, Wilkinson, T): 79–87. University of Otago, 2013.
14Fergusson, DM, Horwood, LJ. The Christchurch Health and Development Study: review of findings on child and adolescent mental health. Aust N Z J Psychiatry 2001; 35: 287–96.
15Adkins, DE, Clark, SL, Copeland, WE, Kennedy, M, Conway, K, Angold, A, et al. Genome-wide meta-analysis of longitudinal alcohol consumption across youth and early adulthood. Twin Res Hum Genet 2015; 18: 335–47.
16Fergusson, DM, Horwood, LJ, Miller, A, Kennedy, MA. Life stress, 5-HTTLPR and mental disorder: Findings from a 30 year longitudinal study. Br J Psychiatry 2011; 198: 129–35.
17Martin, AR, Gignoux, CR, Walters, RK, Wojcik, GL, Neale, BM, Gravel, S, et al. Human demographic history impacts genetic risk prediction across diverse populations. Am J Hum Genet 2017; 100: 635–49.
18The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015; 526: 68–74.
19Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–75.
20American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. American Psychiatric Association, 1994.
21World Health Organization. Composite International Diagnostic Interview (CIDI). World Health Organization, 1993.
22RC Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2014.
23Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995; 57: 289–300.
24Angst, J, Azorin, J-M, Bowden, CL, Perugi, G, Vieta, E, Gamma, A, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode the BRIDGE study. Arch Gen Psychiatry 2011; 68: 791–9.
25Meyer, TD, Schrader, J, Ridley, M, Lex, C. The Hypomania Checklist (HCL) - Systematic review of its properties to screen for bipolar disorders. Compr Psychiatry 2014; 55: 1310–21.
26Forty, L, Smith, D, Jones, L, Jones, I, Caesar, S, Fraser, C, et al. Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32). J Affect Disord 2009; 114: 68–73.
27Carta, MG, Hardoy, MC, Cadeddu, M, Murru, A, Campus, A, Morosini, PL, et al. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Mood Disorder Questionnaire (MDQ) in a clinical sample. Clin Pract Epidemol Ment Health 2006; 2: 2.
28Court, H, Forty, L, Jones, L, Gordon-Smith, K, Jones, I, Craddock, N, et al. Improving the psychometric utility of the hypomania checklist (HCL-32): a Rasch analysis approach. J Affect Disord 2014: 152–4, 448–53.
29Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371–9.